Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 2
2002 2
2003 2
2004 2
2005 2
2006 8
2007 8
2008 27
2009 20
2010 15
2011 22
2012 27
2013 35
2014 36
2015 50
2016 38
2017 34
2018 34
2019 44
2020 34
2021 39
2022 23
2023 26
2024 10
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

488 results

Results by year

Filters applied: . Clear all
Page 1
Treatable traits in the NOVELTY study.
Agustí A, Rapsomaniki E, Beasley R, Hughes R, Müllerová H, Papi A, Pavord ID, van den Berge M, Faner R; NOVELTY Study Investigators. Agustí A, et al. Respirology. 2022 Nov;27(11):929-940. doi: 10.1111/resp.14325. Epub 2022 Jul 21. Respirology. 2022. PMID: 35861464 Free PMC article.
Spirometry and Bronchodilator Test.
Sim YS, Lee JH, Lee WY, Suh DI, Oh YM, Yoon JS, Lee JH, Cho JH, Kwon CS, Chang JH. Sim YS, et al. Among authors: oh ym. Tuberc Respir Dis (Seoul). 2017 Apr;80(2):105-112. doi: 10.4046/trd.2017.80.2.105. Epub 2017 Mar 31. Tuberc Respir Dis (Seoul). 2017. PMID: 28416951 Free PMC article. Review.
Dilemma of Asthma Treatment in Mild Patients.
Cho YS, Oh YM. Cho YS, et al. Among authors: oh ym. Tuberc Respir Dis (Seoul). 2019 Jul;82(3):190-193. doi: 10.4046/trd.2018.0013. Epub 2018 Sep 28. Tuberc Respir Dis (Seoul). 2019. PMID: 30302951 Free PMC article. Review.
Novel anti-CD73-IL-2v bispecific fusion protein augments antitumor immunity by alleviating immunosuppressive adenosine pathways in CD8+ T cells.
Shin K, Park M, Kim S, Lee H, Lee Y, Kim J, Park S, Kim J, Lee K, Park CW, Kim JH, Lee EJ, Mok H, Oh SM, Lee S, Oh YM, Lee W, Shim YA, Cho YG, Park J, Lee JY, Koh YJ, Kim KH, Jang MH. Shin K, et al. Among authors: oh ym. J Immunother Cancer. 2025 Mar 13;13(3):e008594. doi: 10.1136/jitc-2023-008594. J Immunother Cancer. 2025. PMID: 40081940 Free PMC article.
488 results